As biopharma organisations move beyond AI experimentation and into enterprise-scale deployment, leaders face a critical challenge: determining which capabilities to build internally, which to buy from external providers, and where strategic partnerships can accelerate innovation. While technology decisions remain important, successful AI transformation requires balancing speed, differentiation, governance, and long-term business value.
This fireside chat will explore how leading organisations are making build-versus-buy decisions across research, clinical development, medical affairs, commercial operations, and business development while creating scalable AI foundations for the future.
Beyond technology selection, the discussion will focus on the human side of AI transformation: driving adoption, building trust, and embedding AI into everyday workflows. Fire side chat Panelist will share lessons learned on overcoming "pilot purgatory," measuring business impact, establishing effective operating models, and enabling employees to confidently embrace AI-enabled ways of working. Attendees will gain practical insights into moving from isolated AI initiatives to sustainable enterprise adoption, where success is driven not only by the technology selected, but by the people, processes, and behaviors that bring AI to life.
